• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较多纹理纤维化分析与基于二元不透明度的异常检测用于特发性肺纤维化的定量评估。

Comparing multi-texture fibrosis analysis versus binary opacity-based abnormality detection for quantitative assessment of idiopathic pulmonary fibrosis.

作者信息

Nowak Sebastian, Creuzberg Dominik, Theis Maike, Pizarro Carmen, Isaak Alexander, Pieper Claus C, Luetkens Julian A, Skowasch Dirk, Sprinkart Alois M, Kütting Daniel

机构信息

Department of Diagnostic and Interventional Radiology, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.

Department of Internal Medicine II, Cardiology/Pneumology, University Hospital Bonn, Bonn, Germany.

出版信息

Sci Rep. 2025 Jan 9;15(1):1479. doi: 10.1038/s41598-025-85135-7.

DOI:10.1038/s41598-025-85135-7
PMID:39789082
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11718064/
Abstract

Automated tools for quantification of idiopathic pulmonary fibrosis (IPF) can aid in ensuring reproducibility, however their complexity and costs can differ substantially. In this retrospective study, two automated tools were compared in 45 patients with biopsy proven (12/45) and imaging-based (33/45) IPF diagnosis (mean age 74 ± 9 years, 37 male) for quantification of pulmonary fibrosis in CT. First, a tool that identifies multiple characteristic lung texture features was applied to measure multi-texture fibrotic lung (MTFL) by combining the amount of ground glass, reticulation, and honeycombing. Opacity-based fibrotic lung (OFL) was measured by a second tool that performs a simpler binary classification of tissue into either normal or opacified lung and was originally developed for quantifying pneumonia. Differences in quantification of MTFL and OFL were assessed by Mann-Whitney U-test and Pearson correlation (r). Also, correlation with spirometry parameters (percent predicted total lung capacity (TLC), percent predicted vital capacity (VC), percent predicted forced expiratory volume in 1 s (FEV), diffusing capacity of the lungs for carbon monoxide (DL), partial pressure of oxygen (P) and carbon dioxide (P)) were assessed by r. The prognostic values for 3-year patient survival of OFL, LSS and MTFL were investigated by multivariable Cox-proportional-hazards (CPH) models including sex, age and TLC and including sex, age and VC. Also, Kaplan-Meier analysis with log rank test between subgroups separated by median OFL and MTFL were conducted. No significant difference between OFL and MTFL was observed (median and interquartile range: OFL = 29% [20-38%], MTFL = 31% [19-45%]; P = 0.44). For OFL significant correlation was observed to MTFL (r = 0.93, P < 0.01) and VC (r=-0.50, P = 0.03). For MTFL no significant correlation to spirometry parameters was found. The total time for one analysis was lower for the automated MTFL (MTFL: 313 ± 25s vs. OFL: 612 ± 61s, P < 0.001). Both analyses were significant predictors in the multivariable CPH analysis including TLC (hazard-ratios: MTFL 1.03 [1.01-1.06], P = 0.02; OFL 1.03 [1.00-1.06], P = 0.03). No parameter was a significant predictor in the CPH models including VC (hazard-ratios: MTFL 1.01 [0.98-1.04], P = 1; OFL 1.01 [0.97-1.05], P = 1). OFL showed significance in Kaplan-Meier analysis (MTFL: P = 0.17; OFL: P = 0.03). Using a simple opacity-based quantification of pulmonary fibrosis in IPF patients displayed similar results and prognostic value compared to a more complex multi-texture based analysis.

摘要

用于量化特发性肺纤维化(IPF)的自动化工具有助于确保可重复性,但其复杂性和成本可能有很大差异。在这项回顾性研究中,对45例经活检证实(12/45)和基于影像学诊断(33/45)为IPF的患者(平均年龄74±9岁,男性37例)使用两种自动化工具对CT中的肺纤维化进行量化。首先,应用一种识别多种特征性肺纹理特征的工具,通过结合磨玻璃影、网状影和蜂窝状影的数量来测量多纹理纤维化肺(MTFL)。基于密度的纤维化肺(OFL)通过第二种工具测量,该工具对组织进行更简单的二分类,分为正常肺或混浊肺,最初是为量化肺炎而开发的。通过曼-惠特尼U检验和皮尔逊相关性(r)评估MTFL和OFL量化的差异。此外,通过r评估与肺功能参数(预测总肺容量百分比(TLC)、预测肺活量百分比(VC)、预测1秒用力呼气量百分比(FEV)、肺一氧化碳弥散量(DL)、氧分压(P)和二氧化碳分压(P))的相关性。通过多变量Cox比例风险(CPH)模型研究OFL、LSS和MTFL对患者3年生存率的预后价值,模型包括性别、年龄和TLC以及性别、年龄和VC。此外,对按OFL和MTFL中位数分开的亚组进行了Kaplan-Meier分析和对数秩检验。未观察到OFL和MTFL之间存在显著差异(中位数和四分位间距:OFL = 29% [20 - 38%],MTFL = 31% [19 - 45%];P = 0.44)。观察到OFL与MTFL显著相关(r = 0.93,P < 0.01)以及与VC显著相关(r = -0.50,P = 0.03)。对于MTFL,未发现与肺功能参数有显著相关性。自动化MTFL单次分析的总时间更短(MTFL:313±25秒 vs. OFL:612±61秒,P < 0.001)。在包括TLC的多变量CPH分析中,两种分析都是显著的预测指标(风险比:MTFL 1.03 [1.01 - 1.06],P = 0.02;OFL 1.03 [1.00 - 1.06],P = 0.03)。在包括VC的CPH模型中,没有参数是显著的预测指标(风险比:MTFL 1.01 [0.98 - 1.04],P = 1;OFL 1.01 [0.97 - 1.05],P = 1)。OFL在Kaplan-Meier分析中显示出显著性(MTFL:P = 0.17;OFL:P = 0.03)。与更复杂的基于多纹理的分析相比,在IPF患者中使用简单的基于密度的肺纤维化量化显示出相似的结果和预后价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61a4/11718064/37a26182d5a5/41598_2025_85135_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61a4/11718064/9839de1b2151/41598_2025_85135_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61a4/11718064/5d0e9a92e73c/41598_2025_85135_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61a4/11718064/b67a91b301bc/41598_2025_85135_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61a4/11718064/02d53fb436e0/41598_2025_85135_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61a4/11718064/37a26182d5a5/41598_2025_85135_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61a4/11718064/9839de1b2151/41598_2025_85135_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61a4/11718064/5d0e9a92e73c/41598_2025_85135_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61a4/11718064/b67a91b301bc/41598_2025_85135_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61a4/11718064/02d53fb436e0/41598_2025_85135_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61a4/11718064/37a26182d5a5/41598_2025_85135_Fig5_HTML.jpg

相似文献

1
Comparing multi-texture fibrosis analysis versus binary opacity-based abnormality detection for quantitative assessment of idiopathic pulmonary fibrosis.比较多纹理纤维化分析与基于二元不透明度的异常检测用于特发性肺纤维化的定量评估。
Sci Rep. 2025 Jan 9;15(1):1479. doi: 10.1038/s41598-025-85135-7.
2
Quantitative CT analysis of idiopathic pulmonary fibrosis and correlation with lung function study.特发性肺纤维化的定量 CT 分析及其与肺功能研究的相关性。
BMC Pulm Med. 2024 Sep 5;24(1):437. doi: 10.1186/s12890-024-03254-9.
3
Prediction of survival by texture-based automated quantitative assessment of regional disease patterns on CT in idiopathic pulmonary fibrosis.基于 CT 纹理分析的特化区域疾病模式自动定量评估对特发性肺纤维化患者生存的预测。
Eur Radiol. 2018 Mar;28(3):1293-1300. doi: 10.1007/s00330-017-5028-0. Epub 2017 Sep 19.
4
Prognostic value of deep learning-based fibrosis quantification on chest CT in idiopathic pulmonary fibrosis.基于深度学习的胸部 CT 纤维化定量对特发性肺纤维化的预后价值。
Eur Radiol. 2023 May;33(5):3144-3155. doi: 10.1007/s00330-023-09534-y. Epub 2023 Mar 16.
5
Clinical Impact of Emphysema Evaluated by High-Resolution Computed Tomography on Idiopathic Pulmonary Fibrosis Diagnosed by Surgical Lung Biopsy.通过高分辨率计算机断层扫描评估的肺气肿对经外科肺活检诊断的特发性肺纤维化的临床影响。
Respiration. 2016;92(4):220-228. doi: 10.1159/000448118. Epub 2016 Aug 31.
6
Chronic hypersensitivity pneumonitis or idiopathic pulmonary fibrosis? Diagnostic role of high resolution Computed Tomography (HRCT).慢性过敏性肺炎还是特发性肺纤维化?高分辨率计算机断层扫描(HRCT)的诊断作用。
Radiol Med. 2003 Sep;106(3):135-46.
7
Automatic quantitative computed tomography measurement of longitudinal lung volume loss in interstitial lung diseases.自动定量计算机断层扫描测量间质性肺疾病的肺容量纵向损失。
Eur Radiol. 2022 Jun;32(6):4292-4303. doi: 10.1007/s00330-021-08482-9. Epub 2022 Jan 14.
8
Quantitative CT-analysis of over aerated lung tissue and correlation with fibrosis extent in patients with idiopathic pulmonary fibrosis.特发性肺纤维化患者过度充气肺组织的定量 CT 分析及其与纤维化程度的相关性。
Respir Res. 2024 Oct 5;25(1):359. doi: 10.1186/s12931-024-02970-4.
9
Amount of elastic fibers predicts prognosis of idiopathic pulmonary fibrosis.弹性纤维含量可预测特发性肺纤维化的预后。
Respir Med. 2013 Oct;107(10):1608-16. doi: 10.1016/j.rmed.2013.08.008. Epub 2013 Aug 29.
10
The predictors of mortality in IPF - Does emphysema change the prognosis?特发性肺纤维化的死亡预测因素——肺气肿会改变预后吗?
Sarcoidosis Vasc Diffuse Lung Dis. 2016 Oct 7;33(3):267-274.

引用本文的文献

1
Integrating Radiomics Signature into Clinical Pathway for Patients with Progressive Pulmonary Fibrosis.将影像组学特征整合到进行性肺纤维化患者的临床路径中。
Diagnostics (Basel). 2025 Jan 24;15(3):278. doi: 10.3390/diagnostics15030278.

本文引用的文献

1
CT evaluation of interstitial lung disease related to systemic sclerosis: visual versus automated assessment. A systematic review.CT 评价系统性硬化症相关间质性肺病:视觉评估与自动评估。系统综述。
Clin Radiol. 2024 Mar;79(3):e440-e452. doi: 10.1016/j.crad.2023.11.022. Epub 2023 Dec 9.
2
Criteria for Progressive Pulmonary Fibrosis: Getting the Horse Ready for the Cart.进行性肺纤维化的诊断标准:本末倒置
Am J Respir Crit Care Med. 2023 Jan 1;207(1):11-13. doi: 10.1164/rccm.202208-1639ED.
3
Automated Quantification of CT Patterns Associated with COVID-19 from Chest CT.
胸部CT中与COVID-19相关的CT模式的自动定量分析
Radiol Artif Intell. 2020 Jul 29;2(4):e200048. doi: 10.1148/ryai.2020200048. eCollection 2020 Jul.
4
Readily accessible CT scoring method to quantify fibrosis in IPF.易于获取的 CT 评分方法,用于量化特发性肺纤维化中的纤维化。
BMJ Open Respir Res. 2020 Jun;7(1). doi: 10.1136/bmjresp-2020-000584.
5
Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection.胸部计算机断层扫描在 2019 年冠状病毒病(COVID-19)中的表现:与感染持续时间的关系。
Radiology. 2020 Jun;295(3):200463. doi: 10.1148/radiol.2020200463. Epub 2020 Feb 20.
6
SciPy 1.0: fundamental algorithms for scientific computing in Python.SciPy 1.0:Python 中的科学计算基础算法。
Nat Methods. 2020 Mar;17(3):261-272. doi: 10.1038/s41592-019-0686-2. Epub 2020 Feb 3.
7
Quantitative CT Analysis of Diffuse Lung Disease.弥漫性肺疾病的定量 CT 分析。
Radiographics. 2020 Jan-Feb;40(1):28-43. doi: 10.1148/rg.2020190099. Epub 2019 Nov 29.
8
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.尼达尼布治疗进行性纤维化间质性肺疾病。
N Engl J Med. 2019 Oct 31;381(18):1718-1727. doi: 10.1056/NEJMoa1908681. Epub 2019 Sep 29.
9
Idiopathic Pulmonary Fibrosis.特发性肺纤维化
N Engl J Med. 2018 May 10;378(19):1811-1823. doi: 10.1056/NEJMra1705751.
10
Diagnostic criteria for idiopathic pulmonary fibrosis.特发性肺纤维化的诊断标准。
Lancet Respir Med. 2018 Feb;6(2):e6. doi: 10.1016/S2213-2600(18)30020-1.